HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Chari, M. V. Articles by Gadiyar, B. N. Search for Related Content PubMed PubMed Citation Articles by Chari, M. V. Articles by Gadiyar, B. N.

A new Drug (MK-910) in the Therapy of Intestinal and Hepatic Amebiasis

FIRST RESULTS of CLINICAL TRIAL

MK-910, a new drug chemically related to metronidazole, demonstrated marked amebicidal activity in both in vitro and in vivo tests, with a wide margin of safety. We carried out a clinical study of the effectiveness of the drug in 30 patients with hepatic and intestinal amebiasis. Two dosage schedules, 0.5 mg and 1.0 mg of the drug per kg of body weight per day, given orally, proved to be effective for the treatment of both forms of amebiasis. With the exception of transient paresthesia in one patient, there were no side effects or evidence of toxicity. Further clinical trials are required to evaluate more precisely the therapeutic efficacy of the drug.

Accepted for publication July 14, 1970.